Susan L Green

Title: The Innovative Contributions of Susan L. Green

Introduction

Susan L. Green is a notable inventor based in St. Ann, MO (US). She has made significant contributions to the field of cancer treatment through her innovative research and patent. Her work focuses on the use of α-linolenic acid metabolites for the treatment or prevention of cancer, showcasing her dedication to advancing medical science.

Latest Patents

Susan holds a patent for the "Use of α-linolenic acid metabolites for treatment or prevention of cancer." This patent outlines a method for treating or preventing cancer in mammals by administering a cancer-inhibiting amount of metabolites derived from α-linolenic acid. Notable metabolites include stearidonic acid, eicosatetraenoic acid, and docosapentaenoic acid, particularly emphasizing the effectiveness of stearidonic acid.

Career Highlights

Susan is associated with Monsanto Technology LLC, where she has been able to apply her research in a practical setting. Her work has contributed to the understanding of how specific fatty acid metabolites can play a role in cancer prevention and treatment. With her innovative approach, she has positioned herself as a key figure in the field of cancer research.

Collaborations

Throughout her career, Susan has collaborated with esteemed colleagues such as Mark G. Obukowicz and Ayman Kabakibi. These collaborations have further enriched her research and have led to advancements in the understanding of cancer treatment methodologies.

Conclusion

Susan L. Green's contributions to cancer research through her innovative patent highlight her role as a significant inventor in the field. Her work not only showcases her expertise but also reflects her commitment to improving health outcomes through scientific innovation.